에에이프릴바이오: insider trades · South Korea · DART (FSS)
DART:company-04a8beKRKR·DART (FSS)Mcap 1224.3Bn€Healthcare
Discover the full directors' dealings record of 에이프릴바이오, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Healthcare sector, 에이프릴바이오 has logged 1 public disclosures. Market capitalisation: €1,224.3bn. The latest transaction was filed on 10 March 2026 — Other. Among the most active insiders: 에이프릴바이오. Every trade is accessible without an account.
Financial data
FY ended December 2025 · cache
Analyst consensus
1 analysts100000.00 €Target 100000.00 €(+86%)100000.00 €
Income statement
Revenue2.17 Bn€
Gross profit2.17 Bn€100% margin
Net income−9.73 Bn€-447.9% margin
Valuation
PER (forward)-56.2x
Beta1.51
Balance sheet & cash
Market cap1224.34 Bn€
Total debt498.0 M€
Free Cash Flow−3.63 Bn€
Debt / Equity1%
Profitability & ownership
ROE-10.4%
ROA-4.6%
% insiders19.4%
% institutions5.7%
Last declaration on 10 March 2026